SHOCK, CARDIOGENIC
Clinical trials for SHOCK, CARDIOGENIC explained in plain language.
Never miss a new study
Get alerted when new SHOCK, CARDIOGENIC trials appear
Sign up with your email to follow new studies for SHOCK, CARDIOGENIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New antibody drug aims to rescue hearts in shock
Disease control Recruiting nowThis study tests a new drug called procizumab in people with cardiogenic shock, a condition where the heart suddenly can't pump enough blood to vital organs, often leading to death. The drug is designed to block a harmful protein (cDPP3) that rises during shock. About 130 adults …
Matched conditions: SHOCK, CARDIOGENIC
Phase: PHASE1, PHASE2 • Sponsor: 4TEEN4 Pharmaceuticals GmbH • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
Do Heart-Strengthening drugs really help in shock? a major trial aims to find out.
Disease control Recruiting nowThis study looks at whether medicines that help the heart pump stronger (called inotropes) actually help people in cardiogenic shock, a life-threatening condition where the heart can't pump enough blood. About 346 critically ill adults will get either a common inotrope (milrinone…
Matched conditions: SHOCK, CARDIOGENIC
Phase: PHASE4 • Sponsor: Ottawa Heart Institute Research Corporation • Aim: Disease control
Last updated May 11, 2026 20:47 UTC